Eli Lilly & Co. Receives Buy Rating from David Risinger Due to Promising Tirzepatide Trial Results and Competitive Tolerability
Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...
Business Insider on MSN7d
The FDA is about to make weight-loss drugs a lot harder to get
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
JD Supra3d
The GLP-1 Saga Continues: FDA Ends the Tirzepatide Shortage: Frequently Asked Questions
On December 19, 2024, FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly is tirzepatide’s patentholder and the ...
Healthline9d
How to Get a Zepbound Prescription In Person and Online
What is the generic name for Zepbound? The generic name of the active ingredient in Zepbound is tirzepatide. However, Zepbound is not available to buy as a generic drug for weight loss.
TCTMD9d
Misleading Statements Common in Online Ads for Compounded GLP-1s
More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.
Bellevue Reporter14d
The Science Behind GetSimpli Oral Tirzepatide: What Makes It So Effective?
Tirzepatide works by targeting multiple pathways ... from unauthorized retailers or online marketplaces. By choosing to buy directly from the official website, consumers can have peace of mind ...
Business Insider7d
See ya, knock-off Ozempic
The FDA is about to make it a lot harder to get cheap weight-loss drugs Jessica DeBenedetto has only been on compounded tirzepatide for a couple of weeks, but she already feels like it's a life ...
Lexaria Bioscience price target lowered to $7 from $10 at H.C. Wainwright
H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Lexaria Bioscience (LEXX) to $7 from $10 and keeps a Buy rating on the ...